NCT00502567 - A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | Biotech Hunter

Enrollment

104

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

June 30, 2011

Conditions

Advanced Solid Tumor

Interventions

DRUG

AZD2171

oral tablet once daily

DRUG

FOLFOX

intravenous infusion

DRUG

Pemetrexed

intravenous infusion

DRUG

Irinotecan (administered with & without Cetuximab)

intravenous injection

DRUG

Docetaxel

intravenous infusion

Trial Locations (3)

Research Site, Ann Arbor

Research Site, Detroit

Research Site, Nashville